• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 413

Beta glucans derived from Ganoderma lucidum mycelium

Intended Use: As an ingredient in baked goods and baking mixes, beverages and beverage bases, cereal and cereal products, dairy product analogs, milk and milk products, plant protein products, processed fruits and fruit juices, and soft candy at a level of 150 milligrams β-glucans derived from G. lucidum mycelium per serving
Basis: Scientific procedures
Notifier: Super Beta Glucan, Inc.
Notifier Address: 5 Holland, Suite 109
Irvina, CA 92618
Date of filing: Jan 11, 2012
GRAS Notice (releasable information): GRN 413 (in PDF)
Date of closure: Aug 10, 2012
FDA's Letter: FDA has no questions